The assessment considered forecasts of power demand, planned upgrades to the transmission system, public policy and changes ...

A study led by the University of Barcelona and the Spanish National Research Council's Institute for Advanced Chemistry of ...

A study led by the University of Barcelona and the Spanish National Research Council's Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting ...

Sarepta has acquired the global rights to develop ARO-DUX4 and ARO-DM1, two RNAi therapeutic candidates for types of muscular ...

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to ...

In preclinical studies, investigational ARO-ALK7 silenced Activin receptor-like kinase 7 (ALK7) expression in adipose tissue, which led to reduced body ...

The new Dogma meets Thomas Kuhn’s definition of a paradigm shift. The DNA/RNA Dogma is sufficiently unprecedented to attract ...

Ranjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in ...

Despite a rough year, with a -65.45% YTD decline, Serina’s recent financing deal and innovative pipeline suggest that the company is poised for a comeback. Investors will be closely watching the ...

While the presence of residual viral fragments is well-documented, it remains uncertain whether live virus continues to exist ...

Cape Cod Healthcare will participate in a new national clinical research study focused on early detection of lung cancer with ...

Around 5-10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.Researchers have proposed several biological mechanisms to explain long COVID.